Search Prime Grants

HT94252310488

Project Grant

Overview

Grant Description
Targeting cyclic AMP and protein kinase A signaling to treat ADPKD: an efficacious strategy with further potential.
Awardee
Mayo Clinic
Grant Program (CFDA)
12.420 - Military Medical Research and Development
Awarding / Funding Agency
Defense Health Agency (DHA) [DoD]
Place of Performance
Rochester, Minnesota 559050001 United States
Geographic Scope
Single Zip Code
Related Opportunity
W81XWH22PRMRPFPA
Mayo Clinic was awarded Targeting Cyclic AMP Protein Kinase A Signaling ADPKD Treatment Project Grant HT94252310488 worth $8,966,819 from Defense Health Agency in July 2023 with work to be completed primarily in Rochester Minnesota United States. The grant has a duration of 4 years and was awarded through assistance program 12.420 Military Medical Research and Development.

Status
(Ongoing)

Last Modified 6/7/23

Period of Performance
7/1/23
Start Date
6/30/27
End Date
60.0% Complete

Funding Split
$9.0M
Federal Obligation
$0.0
Non-Federal Obligation
$9.0M
Total Obligated
100.0% Federal Funding
0.0% Non-Federal Funding

Activity Timeline

Interactive chart of timeline of amendments to HT94252310488

Additional Detail

Award ID FAIN
HT94252310488
SAI Number
None
Award ID URI
None
Awardee Classifications
Private Institution Of Higher Education
Nonprofit With 501(c)(3) IRS Status (Other Than An Institution Of Higher Education)
Other
Awarding Office
HT9425 ARMY MED RES ACQ ACTIVITY
Funding Office
HT0989 CONG DIR MED RES PRGM / CDMRP - MM
Awardee UEI
Y2K4F9RPRRG7
Awardee CAGE
5A021
Performance District
01
Senators
Amy Klobuchar
Tina Smith
Representative
Brad Finstad

Budget Funding

Federal Account Budget Subfunction Object Class Total Percentage
Defense Health Program, Defense (097-0130) Department of Defense-Military Grants, subsidies, and contributions (41.0) $8,966,819 100%
Modified: 6/7/23